PTP4A3 and breast cancer: This increase in PRL-3 expression during mammary tumour development was closely correlated with an increase in levels of both phosphorylated 4E-BP1 and phosphorylated mTOR on Ser2448, but not total protein expression levels or either (Fig. 1b).